O Schulz,
DJ Pennington,
K Hodivala-Dilke,
M Febbraio,
C Reis e Sousa.
(2002)
" CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells.
"
J Immunol
168.
6057-65
PMID:
12055214
|
Abstract and Keywords
C Peters,
X Peng,
D Douven,
ZK Pan,
Y Paterson.
(2003)
" The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.
"
J Immunol
170.
5176-87
PMID:
12734365
|
Abstract and Keywords
DW Mullins,
SL Sheasley,
RM Ream,
TN Bullock,
YX Fu,
VH Engelhard.
(2003)
" Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control.
"
J Exp Med
198.
1023-34
PMID:
14530375
DOI:
10.1084/jem.20021348
|
Abstract and Keywords
AK Nussbaum,
JL Whitton.
(2004)
" The contraction phase of virus-specific CD8+ T cells is unaffected by a pan-caspase inhibitor.
"
J Immunol
173.
6611-8
PMID:
15557151
DOI:
15557151
|
Abstract and Keywords
PJ Kim,
SY Pai,
M Brigl,
GS Besra,
J Gumperz,
IC Ho.
(2006)
" GATA-3 regulates the development and function of invariant NKT cells.
"
J Immunol
177.
6650-9
PMID:
17082577
|
Abstract and Keywords
AN Courtney,
P Thapa,
S Singh,
AM Wishahy,
D Zhou,
J Sastry.
(2011)
" Intranasal but not intravenous delivery of the adjuvant α-galactosylceramide permits repeated stimulation of natural killer T cells in the lung.
"
Eur J Immunol
41.
3312-22
PMID:
21818755
DOI:
10.1002/eji.201041359
|
Abstract and Keywords
OE Rahma,
E Ashtar,
M Czystowska,
ME Szajnik,
E Wieckowski,
S Bernstein,
VE Herrin,
MA Shams,
SM Steinberg,
M Merino,
W Gooding,
C Visus,
AB Deleo,
JK Wolf,
JG Bell,
JA Berzofsky,
TL Whiteside,
SN Khleif.
(2011)
" A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients.
"
Cancer Immunol Immunother
61.
373-84
PMID:
21927947
DOI:
10.1007/s00262-011-1100-9
|
Abstract and Keywords